Although no statistical difference was shown in the MDA and PKC α relative protein expression among all groups, the protein level of MDA in low, middle, and high dose BFXJY treatment groups was declined compared with that in Qi-yin deficiency + LPS-ATP group (Fig. 4B–D). The gene discussed is PRRT2; the disease is hyperinsulinemic hypoglycemia, familial, 4.